Cellyan Biotechnology Co., LtdHKPD
Price (close)
$0.12
Market cap
$6.0M
P/E
—
Revenue (FY)
$20.3M
Net income
-$27,056
Dividend yield
—
1-year total return
-93.1%
Net margin
-0.1%
Revenue growth
21.7%
Debt / equity
0.30x
What Cellyan Biotechnology Co., Ltd does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | — | $12.6M | $16.7M | $20.3M |
| Net income | — | $998,196 | $1.3M | -$27,056 |
| Free cash flow | — | $1.6M | -$447,066 | $499,298 |
More on HKPD.
- Cellyan Biotechnology Co., Ltd summary
- Cellyan Biotechnology Co., Ltd financial statements
- Cellyan Biotechnology Co., Ltd key metrics
- Cellyan Biotechnology Co., Ltd health scores and style box
- Cellyan Biotechnology Co., Ltd earnings
- Cellyan Biotechnology Co., Ltd dividends
- Cellyan Biotechnology Co., Ltd valuation
- Cellyan Biotechnology Co., Ltd ownership and insiders
- Cellyan Biotechnology Co., Ltd peers
Figures from Cellyan Biotechnology Co., Ltd's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.